Communities most impacted by HIV and STIs have been disproportionately impacted by the 2022 MPX outbreak. Growing calls for urgent action have highlighted the additional stress placed on our already underfunded public health system by a “viral storm” of co-infections between HIV, STIs, MPX, and COVID-19. To respond to this syndemic, local health department (LHD) HIV and STI programs must leverage all tools at their disposal, including new funding flexibilities recently introduced by the CDC.
In October 2022, over 300 health departments joined NACCHO for a webinar featuring Gregorio Millett, Vice President and Director of Policy at amfAR, who discussed key MPX advocacy updates and a syndemic approach to HIV, STIs, COVID-19, and MPX. Presenters from NACCHO also discussed how LHDs can take advantage of the flexibilities that have been made in 18-1802 and EHE funding to support a syndemic approach to HIV/STI/MPX.
A recording of the webinar, titled “Responding to MPX at Local HIV STI Programs Leveraging Resources for a Syndemic Approach,” is available here.
For your reference, we have included below a number of resources discussed in the presentation. For additional questions for our panelists or for federal partners, please email Julia Zigman, Senior Program Analyst for HIV, at [email protected].
- Webinar Recording
- Webinar Slides
- Funding guidance
- Dear Colleague guidance letters on MPX funding allowability:
- Article: Monkeypox response relies on trade-offs without federal aid (Roll Call)
- MPX vaccination resources
- CDC Vaccine Equity Pilot Program
- CDC MPX Vaccine Equity Toolkit
- MPOX Vaccine Locator by Building Healthy Online Communities
- LHD Stories From the Field:
- CDC Interim Considerations for JYNNEOS Vaccine
- Includes vaccine eligibility and new guidance on intradermal vaccination alternative injection locations (i.e., back or upper arm)
- Additional resources